Loading...

VINC - Vincerx Pharma, Inc.

Overbought Signal for 03-11-2024
Overbought Stock Signal: VINC


Loading Chart VINC

Stock Signal Information


Signal

Overbought Stock Signal: VINC
Report Date: 03-11-2024
Symbol: VINC - Vincerx Pharma, Inc.
Sector:
Industry:
Overbought Stock Signal: VINC

  VINC Technical Analysis

Company Contact

Vincerx Pharma, Inc. (VINC)
260 Sheridan Avenue
Palo Alto, CA
Phone: 650 800 6676
Website: http://www.vincerx.com
CEO: Dr. Ahmed M. Hamdy

VINC, Vincerx Pharma, Inc.

VINC Vincerx Pharma, Inc. Logo Image

NASDAQ, Nasdaq Capital Market


Company Profile

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincerx Pharma, Inc. is based in Palo Alto, California.